-
Recent Posts
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
- ReNetX Bio, Inc. Announces U.S. FDA Authorization to Proceed for IND Application to Treat Patients with Chronic Spinal Cord Injury
- Regeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds
- Survey responses needed to help with SCI priorities … Please take a moment
- Putting 3D Printing to Work to Heal Spinal Cord Injury
- Interfering with Semaphorin3A in perineuronal nets to enhance plasticity
- Seeking Feedback on Research Priorities from SCI 2020
- Strategies for Regeneration | Arthur Brown |
- CPAR: Joel Burdick from Caltech on Epidural Spinal Stimulation
- What does “Disruptive” mean? Thoughts on the NIH SCI 2020 meeting
- Combined administration of electro-magnetic stimulation (EMS) at spinal level and at leg muscles to modulate neurophysiological properties at spino-muscular circuitry in healthy and SCI humans
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: Jan-Eric Ahlfors
Human Oligodendrogenic Neural Progenitor Cells Delivered with Chondroitinase ABC Facilitate Functional Repair of Chronic Spinal Cord Injury
Authors: Satoshi Nori, Mohamad Kahazaei, Christopher S. Ahuja, Kazuya Yokota, Jan-Eric Ahlfors, Yang Liu, Jain Wang, Shinsuke Shibata, Jonathon Chio, Marian H Hettiaratchi, Tobias Fuhrmann, Molly S. Shoichet, Michael G. Gehlings Summary: “Treatment of chronic spinal cord injury (SCI) is … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged Christopher S. Ahuja, Jain Wang, Jan-Eric Ahlfors, Jonathon Chio, Kazuya Yokota, Marian H Hettiaratchi, Michael G. Gehlings, Mohamad Kahazaei, Molly S. Shoichet, Satoshi Nori, Shinsuke Shibata, Tobias Fuhrmann, Yang Liu
2 Comments
Fortuna Fix Announces Series B Financing, Adding Amgen Ventures and Macnguyen Family Office as Shareholders
(Newswire.com) Press Release: November 8, 2017 Fortuna Fix – Fortuna Fix (“Fortuna”), a private, clinical-stage Regenerative Medicine company is aiming to be the first to bring to the clinic a patient’s own neural stem cells (autologous) produced by direct reprogramming … Continue reading
Breakthrough Regenerative Therapeutics Company Establishes Scientific Advisory Board
Montreal, Canada, May 4, 2017 (Newswire.com) – Fortuna Fix Inc. (“Fortuna”), a private, clinical-stage biotech company, is aiming to be the first to eliminate the need for embryonic and fetal stem cells by using direct reprogramming of autologous cells to treat … Continue reading
Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged Jan-Eric Ahlfors, MPH; and Professor James Giordano, PhD; Col. (R) Dallas Hack, PhD; Father Kevin FitzGerald, Professor Michael Fehlings
1 Comment
New World Laboratories pushes forward with clinical trial
New World Laboratories acts as its own research center, allowing it to create its own therapeutic platforms. The company focuses its efforts on three main sectors—therapeutic drugs, medical devices, and cell therapies. For example, the apoptosis program (programmed cell death) … Continue reading
